RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients
NCT ID: NCT01102933
Last Updated: 2014-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
425 participants
OBSERVATIONAL
2010-04-30
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Evaluate biomarkers and change of these related to myocardial infarction, during two years follow-up in an unselected patient population with a recent myocardial infarction.
Evaluate if an early change of biomarkers can be related to death, new myocardial infarction, and ischemic stroke in the same population after two and five years follow-up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MI Mortality Risk and Between-hospital Risk Variation in the United Kingdom and Sweden
NCT01359033
Biomarkers Predicting Acute Myocardial Infraction in Patients Without Standard Modifiable Risk Factors
NCT05535582
Biomarkers in Acute Cardiac Care
NCT02355457
Novel Biomarkers in Patients With Acute Myocardial Infarction
NCT05791916
Aiming Towards Evidence Based Interpretation of Cardiac Biomarkers in Patients Presenting With Chest Pain Using Point of Care Assays
NCT05354804
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Unselected post-myocard infarct patients
Patients diagnosed with MI at Uppsala University Hospital
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Treated at the Department of cardiology, Uppsala University Hospital.
3. Ability to attend the scheduled visits for evaluation procedures.
4. Signed Informed Consent.
Exclusion Criteria
2. Not belonging to the catchment area of Uppsala University Hospital.
3. Lack of suitability for participation in the trial, for any reason, as judged by the Investigator.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christina Christersson, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Cardiology Department, Uppsala University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiology Department
Uppsal University Hospital, Uppsala County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U-09-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.